Annals of Oncology · 2016 · 59 citations · 27 references
MedicineOncologyPharmacologyBreast OncologyMolecular OncologyTumor ProgressionBreast Cancer PharmacotherapyHer2-positive Breast CancerMetastatic Breast CancerMetastatic Cancer ManagementMetastatic Disease TreatmentTargeted TherapyHer2 ExpressionHer2 InhibitorsHer2 Receptor TargetingHer2-positive Breast Cancer TherapyHer2-positive Metastatic DiseaseHuman Epidermal Growth Factor Receptor 2-Targeted TherapyMetastatic Breast Cancer TreatmentMetastatic Her2-positive Breast Cancer
27
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17